Diabetes exacerbates the progression of atherosclerosis and is associated with increased
risk of developing acute coronary syndrome (ACS). Approximatively 25–30% of patients …

Following myocardial ischemic injury, the most effective clinical intervention is timely
restoration of blood perfusion to ischemic but viable myocardium to reduce irreversible …

BACKGROUND: The no-reflow phenomenon is associated with a considerable reduction in
myocardial salvage in patients with ST elevation myocardial infarction (STEMI) treated by …

Background. Distal embolization due to microthrombus fragments formed during predilation
ballooning is considered one of the possible mechanisms of slow flow/no‐reflow (SF/NR) …

Background Patients with diabetes mellitus (DM) caused by obesity have increased in
recent years. The impact of obesity on long-term outcomes in patients undergoing …

Objectives Thrombotic process is triggered in the course of Coronavirus disease-2019
(COVID-19), which is a global pandemic, and both arterial and venous systems are affected …

Blood flow restoration after primary percutaneous coronary intervention (pPCI) in patients
with acute myocardial infarction (AMI) may not always be achieved and could be …

Background: Ineffective myocardial perfusion despite angiographic success after
angioplasty occurs frequently and is associated with an increased risk of mortality. Hence …

Aims To describe the utility and safety of intravascular lithotripsy (IVL) in the setting of
primary percutaneous coronary intervention (PCI) for ST elevation myocardial infarction …

BACKGROUND: Suboptimal coronary reperfusion (no reflow) is common in acute coronary
syndrome percutaneous coronary intervention (PCI) and is associated with poor outcomes …